Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05503862 · ClinicalTrials.gov registry record · NA
Home Semen Testing in Men Beginning Attempts to Conceive
A NA study of Male Infertility, sponsored by Northwestern University.
- Active
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT05503862 is a NA study of Male Infertility that is active but no longer recruiting, run by Northwestern University. The registered enrollment target is 200 participants, below the 533-participant average among 8 other Male Infertility trials with a reported enrollment target (62% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05503862, a NA study of Male Infertility, is active but no longer recruiting, sponsored by Northwestern University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
The overall objective of the proposed study is to enhance early detection of male factor infertility and reduce cost and morbidity associated with delayed diagnosis through development of a universal screening model based on home semen testing. The advent of inexpensive and accurate home semen testing has enabled a potential paradigm shift in the approach to male fertility evaluation. The investigator's central hypothesis is that universal home semen testing prior to attempts to conceive is easy for participants and can lead to reduced fertility-related anxiety and early detection of male factor infertility, thereby expediting evaluation and treatment for the couple while minimizing unnecessary cost and morbidity. This study is specifically designed to assess the feasibility and utility of home semen testing for couples who are beginning attempts to conceive. First, the investigator will assess participants' ability to complete the home semen testing, ease of use, and obstacles encountered in doing so. Second, the investigator will examine the impact of home semen testing in fertility-related quality of life among couples beginning attempts to conceive, as well as ability of home semen testing to increase the diagnosis and treatment of male infertility in these couples.
Conditions Studied
Interventions
- DEVICE YoSperm
Study Locations (1)
Illinois
- Northwestern University Department of Urology - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2022-09-09 |
| Est. Completion | 2025-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05503862
The ClinicalTrials.gov registry entry for NCT05503862 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 533-participant average among 8 other Male Infertility trials with a reported enrollment target (62% lower). The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Male Infertility appearing as the primary indexed condition, and to 1 intervention - of which YoSperm is the first listed.
NCT05503862 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT05503862 about?
NCT05503862 is a clinical study titled "Home Semen Testing in Men Beginning Attempts to Conceive". The overall objective of the proposed study is to enhance early detection of male factor infertility and reduce cost and morbidity associated with delayed diagnosis through development of a universal screening model based on home semen testing. The advent of inexpensive and accurate home semen testi...
What is the current status of trial NCT05503862?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2022-09-09. Estimated completion is 2025-10.
What conditions does trial NCT05503862 study?
This clinical trial studies the following conditions: Male Infertility.
What interventions are being tested in trial NCT05503862?
The interventions under investigation include: YoSperm (DEVICE).
Who is sponsoring clinical trial NCT05503862?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05503862 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Male Infertility
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Platelet Rich Plasma Testis Treatment for Infertile Men
RECRUITING · NA
-
To Investigate if the Harvester® Improves Sperm Motility and Blastocyst Utilization (the Percent of Fertilized Eggs That Develop to the Point That They Are Able to be Transferred) in IVF Cycles.
ACTIVE NOT RECRUITING · NA
-
Male Infertility and Assisted Reproductive Technologies Research Biobank
RECRUITING
-
SpermQT Prospective Observational Trial
ACTIVE NOT RECRUITING
-
A Pilot Study to Evaluate the Effect of Pomegranate Juice on Semen Parameters in Healthy Male Volunteers
COMPLETED · Phase 1
-
Small RNA Pathways in Mammalian Gametogenesis
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.